| |
| |
|
| Insider
Information: |
Malik Shahzad |
| Relationship: |
Director |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
30,402 |
|
|
Indirect Shares
|
9,525,519 |
|
|
| Direct
Value |
$168,133 |
|
|
|
Indirect Value
|
$115,836,414 |
|
|
| Total
Shares |
9,555,921 |
|
|
| Total
Value |
$116,004,547 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Histogen Inc |
HSTO |
Director, 10% Owner |
2013-07-30 |
0 |
2013-07-30 |
2,166,836 |
Premium* |
|
|
Antigenics Inc |
AGEN |
Director |
|
0 |
2015-05-27 |
1,587,302 |
Premium* |
|
|
Aravive Inc |
ARAV |
Director |
2017-12-20 |
23,880 |
2017-12-20 |
1,621,558 |
Premium* |
|
|
Iterum Therapeutics Plc |
ITRM |
Director |
2018-05-30 |
0 |
2018-05-30 |
838,325 |
Premium* |
|
|
Axonics Modulation Technologies,... |
AXNX |
Director |
2018-12-06 |
2,500 |
2018-12-06 |
1,694,349 |
Premium* |
|
|
Acutus Medical, Inc. |
AFIB |
Director |
2021-06-17 |
4,022 |
2021-06-17 |
1,617,149 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AFIB |
Acutus Medical, Inc. |
Director |
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,800 |
4,022 |
0 |
- |
|
| AFIB |
Acutus Medical, Inc. |
Director |
– • – |
2020-08-10 |
4 |
A |
$0.00 |
$0 |
I/I |
1,617,149 |
1,551,713 |
0 |
- |
|
| AFIB |
Acutus Medical, Inc. |
Director |
– • – |
2020-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,222 |
2,222 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Director |
– • – |
2018-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
Former 10% Owner |
– • – |
2018-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,694,349 |
1,694,349 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2018-05-30 |
4 |
B |
$13.00 |
$3,080,792 |
I/I |
236,984 |
838,325 |
2.1 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
I/I |
631,177 |
609,485 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2017-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
11,200 |
23,880 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,480 |
12,680 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2017-03-17 |
4 |
S |
$18.01 |
$6,958,470 |
I/I |
(386,367) |
1,621,558 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2017-03-16 |
4 |
S |
$18.50 |
$1,800,106 |
I/I |
(97,303) |
2,007,925 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2017-03-15 |
4 |
S |
$19.08 |
$1,967,568 |
I/I |
(103,122) |
2,105,228 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2017-03-14 |
4 |
S |
$19.00 |
$890,685 |
I/I |
(46,878) |
2,208,350 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2017-03-13 |
4 |
S |
$19.42 |
$317,129 |
I/I |
(16,330) |
2,255,228 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • • |
2016-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,625 |
9,200 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • • |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,575 |
4,575 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Director |
– • – |
2015-05-27 |
4 |
A |
$6.30 |
$10,000,003 |
I/I |
1,587,302 |
1,587,302 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Director |
– • – |
2015-04-29 |
4 |
S |
$7.02 |
$2,858,809 |
I/I |
(407,377) |
0 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Director |
– • – |
2015-04-28 |
4 |
S |
$7.16 |
$5,012,560 |
I/I |
(700,000) |
407,377 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • – |
2015-01-22 |
4 |
B |
$17.25 |
$948,750 |
I/I |
55,000 |
2,271,558 |
2.1 |
- |
|
| AGEN |
Antigenics Inc |
Director |
– • – |
2014-05-08 |
4 |
A |
$3.00 |
$333,756 |
I/I |
111,289 |
1,107,377 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • • |
2014-03-26 |
4 |
A |
$0.00 |
$0 |
I/I |
2,156,558 |
2,156,558 |
0 |
- |
|
| ARAV |
Aravive Inc |
Director |
– • • |
2014-03-26 |
4 |
B |
$21.00 |
$1,260,000 |
I/I |
60,000 |
2,216,558 |
2.25 |
- |
|
| AGEN |
Antigenics Inc |
Director |
– • – |
2014-02-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
996,088 |
|
- |
|
| HSTO |
Histogen Inc |
Director |
– • • |
2013-07-30 |
4 |
B |
$11.00 |
$2,090,594 |
I/I |
190,054 |
2,166,836 |
2.25 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
